Swaiman K F, Machen V L
Ann Neurol. 1984 Jul;16(1):66-70. doi: 10.1002/ana.410160113.
Although iron accumulates in the brain in a number of pathological conditions, including Hallervorden-Spatz syndrome, Parkinson's disease, and neurosyphilis, studies of brain iron metabolism have been performed only rarely. Neuronal-enriched cultures were prepared from fetal mouse brain. After 18 days the cells were exposed to radiolabeled iron. Total iron uptake and incorporation into ferritin were rapid and linear over four hours. The addition of either methylamine or ammonium chloride, both known blockers of transferrin-iron release through their lysosomotropic properties, inhibited total iron uptake. Methylamine also inhibited the rate of ferritin-iron incorporation, most likely by interfering with transferrin-iron release. The data suggest that neuronal iron transport, much like that in other mammalian tissues, is transferrin mediated and that blockers of transferrin-iron release may be of value in conditions in which there is brain iron overload.
尽管在包括哈勒沃登 - 施帕茨综合征、帕金森病和神经梅毒在内的多种病理状况下,铁会在大脑中蓄积,但对脑铁代谢的研究却很少进行。从胎鼠脑制备了富含神经元的培养物。18天后,将细胞暴露于放射性标记的铁。在4小时内,总铁摄取和铁掺入铁蛋白的过程迅速且呈线性。已知通过其溶酶体亲和特性阻断转铁蛋白 - 铁释放的甲胺或氯化铵的添加,抑制了总铁摄取。甲胺还抑制了铁蛋白 - 铁掺入的速率,很可能是通过干扰转铁蛋白 - 铁的释放。数据表明,神经元铁转运与其他哺乳动物组织中的情况非常相似,是由转铁蛋白介导的,并且转铁蛋白 - 铁释放的阻断剂在存在脑铁过载的情况下可能具有价值。